Do you want to read an article? Please log in or register.
Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD
COPD
Related content
COPD
Development and Validation of a Quantitative Score for the Criteria Clinical Control in Stable COPD Proposed in the Spanish COPD Guidelines (GesEPOC): Results of the EPOCONSUL Audit
J Clin Med
Calle Rubio M, Cataluña JJS, Miravitlles M, Navarrete BA, López-Campos JL, Ferrer MEF, Rodríguez Hermosa JL
doi: 10.3390/jcm14030707
COPDLung Cancer
Construction and Validation of a Nomogram Prediction Model for Death Risk in Patients with Chronic Obstructive Pulmonary Disease Complicated by Hypercapnic Respiratory Failure in the Intensive Care Unit
Respir Med
Zhang Y, Chen H, Hu S, Chen C, Chen W
doi: 10.1016/j.rmed.2025.108188
COPD
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study
Sci Rep
Ogata H, Tsubouchi K, Takano T, Ichiki K, Torii R, Takata S, Nakagaki N, Yoshida M, Kitasato Y, Tobino K, Harada E, Wataya H, Ishii H, Maeyama T, Kawasaki M, Fujita M, Yatera K, Zaizen Y, Nakanishi Y, Okamoto I
doi: 10.1038/s41598-025-05033-w
Lung Cancer
Time-to-Event Modeling for Survival Prediction of Osimertinib as the First- and Second-Line Therapy
J Clin Med
Lee S, Kim H, Lee H, Hahn J, Chang MJ
doi: 10.3390/jcm14124077
COPD
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice
Semin Respir Crit Care Med
Sartori F, Sartori G, Di Chiara C, Fantin A, Crisafulli E
doi: 10.1055/a-2693-0577
RECOMMENDED
COPD
The impact of sensitization patterns on COPD severity and exacerbations: Insights from a case-control and longitudinal study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur J Intern Med
Karakioulaki M, Berkemeier CM, Grize L, Heijnen I, Polyzos SA, Goulas A, Tamm M, Stolz D
doi: 10.1016/j.ejim.2025.04.001
RECOMMENDED
Pneumonia
Prediction of mortality risk in patients with severe community-acquired pneumonia in the intensive care unit using machine learning
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Pan J, Guo T, Kong H, Bu W, Shao M, Geng Z
doi: 10.1038/s41598-025-85951-x
COMMENTED
COPD
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med
Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID, MATINEE Study Investigators
doi: 10.1056/NEJMoa2413181
COPD
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Respir Med
Vogelmeier CF, Rabe KF, Bhatt SP, Hanania NA, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Maloney J, Dakin P, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM
doi: 10.1016/j.rmed.2025.108015